"Nolevo" morning after pill likely to approve in Nov.
Published: 2001-09-17 06:59:00
Updated: 2001-09-17 06:59:00
The health registration for Nolevo, a morning after pill, seems to get KFDA approval around coming Nov. after the public hearing in Oct., said KFDA chief commissioner Yang Kyu-whan in the parliamentary inspection meeting on Sept. 11.
When the public hearing is considered as a nothing but a for...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
